For example, loss of AOX1 expression by epigenetic regulation could promote bladder cancer via metabolic deregulations; the SNP rs73055188 of AOX1 locus is related to prostate cancer survival time, and AOX1 gene expression level is correlated with recurrence of prostate cancer [44]. This evidence concerns the gene AOX1 and urinary bladder cancer.